These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11007259)

  • 1. Primary biliary cirrhosis exacerbated by a course of acute hepatitis C and subsequent interferon therapy.
    Yoshikawa M; Mimura M; Shiroi A; Kojima H; Fukui H; Sugimoto Y; Mochi T
    Am J Gastroenterol; 2000 Sep; 95(9):2396-7. PubMed ID: 11007259
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.
    Tong MJ; Lai LP; Murakami-Mori K
    West J Med; 1997 Aug; 167(2):103-5. PubMed ID: 9291751
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hepatitis C infection: an indication for alfa interferon therapy?
    van der Vlies CH; Tang TJ; Niesters HG; Zondervan PE; Janssen HL; de Man RA
    Neth J Med; 2000 Jul; 57(1):30-3. PubMed ID: 10863000
    [No Abstract]   [Full Text] [Related]  

  • 4. [The management of acute hepatitis C and needlestick accidents with hepatitis-C virus positive blood].
    Cooreman MP; Weegink C; Reesink HW
    Ned Tijdschr Geneeskd; 1998 Oct; 142(42):2298-300. PubMed ID: 9864524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C.
    Fabris P; Tositti G; Giordani MT; Infantolino D; de LF
    Am J Gastroenterol; 2002 Feb; 97(2):492-3. PubMed ID: 11866300
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained viral response of a case of acute hepatitis C virus infection via needle-stick injury.
    Kogure T; Ueno Y; Kanno N; Fukushima K; Yamagiwa Y; Nagasaki F; Kakazu E; Matsuda Y; Kido O; Nakagome Y; Ninomiya M; Shimosegawa T
    World J Gastroenterol; 2006 Aug; 12(29):4757-60. PubMed ID: 16937453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection in dialysis patients.
    Sułowicz W; Radziszewski A; Chowaniec E
    Hemodial Int; 2007 Jul; 11(3):286-95. PubMed ID: 17576291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C.
    Li Z; Zhang Y; An J; Feng Y; Deng H; Xiao S; Ji F
    J Clin Virol; 2014 Jul; 60(3):190-5. PubMed ID: 24830933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.
    Heathcote EJ; Shiffman ML; Cooksley WG; Dusheiko GM; Lee SS; Balart L; Reindollar R; Reddy RK; Wright TL; Lin A; Hoffman J; De Pamphilis J
    N Engl J Med; 2000 Dec; 343(23):1673-80. PubMed ID: 11106716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo occurring at site of interferon-alpha 2b injection in a patient with chronic viral hepatitis C: a case report.
    Anbar TS; Abdel-Rahman AT; Ahmad HM
    Clin Exp Dermatol; 2008 Jul; 33(4):503. PubMed ID: 18498412
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe neutropenia and post-hepatitis C cirrhosis treatment: is interferon dose adaptation at once necessary?
    Renou C; Harafa A; Bouabdallah R; Dematteï C; Cummins C; Rifflet H; Muller P; Ville E; Bertrand J; Benderitter T; Halfon P
    Am J Gastroenterol; 2002 May; 97(5):1260-3. PubMed ID: 12014740
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel.
    Chung H; Kudo M; Kumada T; Katsushima S; Okano A; Nakamura T; Osaki Y; Kohigashi K; Yamashita Y; Komori H; Nishiuma S
    J Gastroenterol; 2003; 38(9):877-9. PubMed ID: 14569445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What are the indications for treatment of acute hepatitis C?].
    Myers RP; Regimbeau C; Moussalli J; Ratziu V; Di Martino V; Thabut D; Bernard B; Benhamou Y; Poynard T
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B188-93. PubMed ID: 12180287
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to peginterferon treatment in hepatitis C virus-associated splenic lymphoma with villous lymphocytes.
    Kanbay M; Selcuk H; Gur G; Dagli N; Karakus S; Yilmaz U
    Am J Hematol; 2006 Apr; 81(4):304-5. PubMed ID: 16550519
    [No Abstract]   [Full Text] [Related]  

  • 17. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain.
    Yachimski P; Chung RT
    AIDS Read; 2004 Oct; 14(10):568-9. PubMed ID: 15510393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.